Skip to main content
. 2022 May 18;10(5):1045. doi: 10.3390/microorganisms10051045

Table 3.

Studies characterizing the composition of the gut microbiota in hepatocellular carcinoma.

Author Reference Country Study Design Participants Changes in the Composition of Gut Microbiota in HCC Key Findings
Human Studies
[79] Poland Cross-sectional 15 HCC
5 without HCC
All participants had cirrhosis and underwent liver transplantation.
Escherichia coli
Enterobacteriaceae
Enterococcus
Lactobacillus
↑ H2O2-producing Lactobacillus species
↑ Fecal counts of E coli were noted in
the cirrhotic-HCC group, demonstrating its role in HCC development
[88] Australia Cohort study;
metagenomics and metabolomics analysis
32 NAFLD-HCC
28 NAFLD-cirrhosis
30 non-NAFLD controls
Proteobacteria
Enterobacteriaceae
Bacteroides xylanisolvens
B. caecimuris
Ruminococcus gnavus
Clostridium bolteae
Veillonella parvula
Bacteroides caecimuris
Veillonella parvula
Clostridium bolteae
Ruminococcus gnavus
Oscillospiraceae
Erysipelotrichaceae
Eubacteriaceae
B. caecimuris and Veillonella parvula distinguished NAFLD-HCC from NAFLD-cirrhosis and non-NAFLD controls
↓ Gut microbial α-diversity
↑ SCFAs serum levels in NAFLD-HCC compared to NAFLD-cirrhosis and non-NAFLD control
Gut microbiota in NAFLD-HCC microbiota contribute to immunosuppression
[89] China Cohort 75 with early HCC
40 liver cirrhosis
75 healthy controls
Actinobacteria
Gemmiger
Parabacteroides
Paraprevotella
Klebsiella
Haemophilus
Verrucomicrobia
Alistipes
Phascolarctobacterium
Ruminococcus
Oscillibacter
Faecalibacterium
Clostridium IV
Coprococcus
↓ Butyrate-producing bacteria
↑ LPS-producing bacteria in early HCC versus healthy controls
[82] China Case-control 57 HCC (35 with HBV related HCC, 22 with non-HBV non-HCV related HCC)
33 healthy controls
Bifidobacterium
Lactobacillus
Proteobacteria
Firmicutes
↓ Anti-inflammatory and ↑ pro-inflammatory bacteria in non-HBC non-HCV related HCC patients which correlated with their increased alcohol consumption
[81] China Case-control 68 with primary HCC:
(23 Stage I,
13 Stage II, 30 Stage III,
2 Stage IV)
18 healthy controls
↑ Dysbiosis index Proteobacteria (Enterobacter, Haemophilus)
Desulfococcus
Prevotella
Veillonella
Cetobacterium
↑ Dysbiosis index in patients with primary HCC compared with healthy controls
[83] Italy Cohort 21 with NAFLD-related cirrhosis with HCC
20 NAFLD-related cirrhosis without HCC
20 healthy controls
Bacteroides
Ruminococcaceae
Bifidobacterium
↑ Fecal calprotectin in HCC patients, which explains increased inflammation
[90] Argentina Case-control 407 Cirrhosis: 25 with HCC, 25 w/o HCC
25 healthy controls
Erysipelotrichaceae
Odoribacter
Butyricimonas
Leuconostocaceae
Fusobacterium
Lachnospiraceae
Prevotella in cirrhotic patients with HCC, which is associated with the activation of several inflammatory pathways such as the NLR signalling pathways
[91] China Case-control 24 PLC
24 cirrhosis
23 healthy controls
Enterobacter ludwigii
Enterococcaceae
Lactobacillales
Bacilli
Gammaproteobacteria
Veillonella
↓ diversity of Firmicutes
Clostridia
Subdoligranulum
Veillonella positively correlated with AFP
Subdoligranulum negatively correlated with AFP
Subdoligranulum contains SCFA-producing lineages
[84] China Case-control 24 hepatitis
24 cirrhosis
75 HCC (35 with HBV, 25 with HCV, 15 with ALD)
20 healthy controls
Neisseria
Enterobacteriaceae
Veillonella
Limnobacter
Enterococcus
Phyllobacterium
Clostridium
Ruminococcus
↓ Coprococcus
↑ LPS by harmful bacteria generated liver inflammatory reactions through TLR4
Animal experimental model studies
[78] Japan Mice 24 STZ-HFD (streptozocin-high-fat diet)-induced
24 controls
Bacteroides
Bacteroides vulgatus
Bacteroides uniformis
Clostridium
Clostridium xylanolyticum
Clostridium fusiformis
Roseburia
Allobaculum sp. id4
Subdoligranulum
Anaerotruncus
Oscillibacter
Xylanibacter
Mucispirillum schaedleri
Pseudobutyrivibrio
Desulfovibrio
Dehalobacterium
Oscillospira
Sarcina
Atopobium
Peptococcus
Parasutterella
Bacteroides acidofaciens
Odoribacter
Barnesiella
Moryella
Paraprevotella
Lactobacillus intestinalis
Akkermansia
Clostridium, Bacteroides, and Desulfovibrio were involved in bile acid dysregulation; their increased levels resulted in the preservation of high concentrations of bile acids, further contributing to hepatocarcinogenesis

AFP, alpha-fetoprotein; ALD, alcohol-associated liver disease; HBV, hepatitis B virus; HCV, hepatitis C virus; HCC, hepatocellular carcinoma LPS, lipopolysaccharide; NAFLD, nonalcoholic fatty liver disease; PLC, primary liver cancer; SCFAs, short-chain fatty acids; ↑, increase; and ↓, decrease.